Scott T. Benken
Clinical Associate Professor, College of Pharmacy
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
PDAT 10: Advanced Disease Mgmt (PHAR 510), 1/8/2024 – 4/26/2024
PDAT 10: Advanced Disease Mgmt (PHAR 510), 1/8/2024 – 4/26/2024
PDAT 10: Advanced Disease Mgmt (PHAR 510), 1/8/2024 – 4/26/2024
PDAT 10: Advanced Disease Mgmt (PHAR 510), 1/8/2024 – 4/26/2024
Spec Project in Pharm Pract (PMPR 390), 8/21/2023 – 12/1/2023
Spec Topics in Pharm Pract (PMPR 385), 8/21/2023 – 12/1/2023
Spec Topics in Pharm Pract (PMPR 385), 8/21/2023 – 12/1/2023
University of Malta Master of Science in Advanced Clinical Pharmacy and Doctor of Pharmacy Program (AKI and Acid Base), 2/1/2023 – 3/31/2023
Critical Care I (PMPR 430), 1/9/2023 – 4/28/2023
Selected Grants
Maribavir Clearance during in vitro Continuous Renal Replacement Therapy, Takeda Pharmaceuticals., 12/12/2023 - 6/1/2025, Obligated Amount: $146513.18; Anticipated Amount: $146513.18
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers, Wake Forest University., 9/5/2023 - 5/31/2024, Obligated Amount: $9194; Anticipated Amount: $9194
Economic outcomes of first-line ANG2 vs. CVP in patients with KT for perioperative hemodynamic maintenance., La Jolla Pharmaceutical Company., 6/30/2023 - Present, Obligated Amount: $120000; No Anticipated Amount Set
VIDAS® NEPHROCLEARTM CCL14 Diagnostic Accuracy Study, bioMerieux., 6/1/2023 - Present, Obligated Amount: $51000; No Anticipated Amount Set
Retrospective Evaluation of Dosing Weight of Tacrolimus Extended Release (Envarsus XR) in Obese Kidney Transplant Recipients in the De Novo Setting, Veloxis Pharmaceuticals., 1/18/2023 - 12/31/2026, Obligated Amount: $49776; Anticipated Amount: $49776
Retrospective Evaluation of Dosing Weight of Tacrolimus Extended Release (Envarsus XR) in Obese Kidney Transplant Recipients in the de novo Setting, Veloxis Pharmaceuticals., 1/18/2023 - 12/31/2026, Obligated Amount: $49776; Anticipated Amount: $49776
CTA: PATIENT CONTROL GROUP ADDENDUM TO THE EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEYCARE ON RENAL ALLOGRAFTS REGISTRY AGREEMENT, CareDX., 1/17/2022 - 1/17/2027, Obligated Amount: $56750; Anticipated Amount: $56750
Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients, Merck Sharp & Dohme Corp., 1/6/2022 - 1/6/2025, No Obligated Amount Set; Anticipated Amount: $137232.72
B3166 : VIDAS� NEPHROCLEARTM CCL14 : Sample Stability Study, Reference number 423961, bioMerieux., 12/9/2021 - 9/15/2024, Obligated Amount: $76998; Anticipated Amount: $76998
Selected Publications
Belcher, Rachel, Mashhad, Sara, Dahlquist, Ashley, Johnson, Jeremy James, Dangi, Bikash, Benedetti, Enrico, Benken, Jamie, Benken, Scott T. (2024). Characterizing the Stability of Angiotensin II in 0.9% Sodium Chloride Using High Performance Liquid Chromatography and Liquid Chromatography Tandem Mass Spectrometry. Hospital Pharmacy, 59, (2), 198-201. doi:10.1177/00185787231206525.
Bestard, Oriol, Augustine, Joshua, Wee, Alvin, Poggio, Emilio, Mannon, Roslyn B, Ansari, Mohammed Javeed, Bhati, Chandra, Maluf, Daniel, Benken, Scott, Leca, Nicolae, La Manna, Gaetano, Samaniego-Picota, Milagros, Shawar, Saed, Concepcion, Beatrice P, Rostaing, Lionel, Alberici, Federico, O’Connell, Phillip, Chang, Anthony, Salem, Fadi, Kattan, Michael W, Gallon, Lorenzo, Donovan, Michael J. (2024). Prospective observational study to validate a next-generation sequencing blood RNA signature to predict early kidney transplant rejection. American Journal of Transplantation, 24, (3), 436-447. doi:10.1016/j.ajt.2023.09.021.
Alzahrani, Mohammed, Belcher, Rachel M, Benken, Jamie, Valdepenas, Benito, Di Cocco, Pierpaolo, Kajavathanan, Mathula, Benken, Scott T. (2023). Retrospective evaluation of LCP‐tacrolimus (Envarsus XR) dosing in de novo kidney transplant. Clinical Transplantation, 37, (11), e15082. doi:10.1111/ctr.15082.
Goldberg, Rachel, Ye, William, Johns, Kevin, Mucksavage, Jeffrey J, Dhandapani, Shvetha, Quigley, John G, Shapiro, Nancy L, Benken, Scott T, Wenzler, Eric, Kim, Keri S. (2023). Comparison of thrombotic and clinical outcomes in SARS-CoV-2-pneumonia versus other viral pneumonia in an urban academic medical center. Heart & Lung, 61, 153-157. doi:10.1016/j.hrtlng.2023.05.005.
Palmer, Mary E, Belcher, Rachel M, Engeleit, Anastasia, Wenzler, Eric, Bulman, Zackery P, Benken, Scott T. (2023). Pharmacokinetics and dialytic clearance of baricitinib during in vivo continuous venovenous haemodialysis in a patient with COVID-19. International Journal of Antimicrobial Agents, 62, (3), 106920. doi:10.1016/j.ijantimicag.2023.106920.
Thomas, Riya, Benken, Jamie, Belcher, Rachel M, Palmer, Mary E, Benedetti, Enrico, Benken, Scott T. (2023). Catecholamine Vasopressor Exposure Is Associated With Early Poor Allograft Function and Adverse Events in Living Donor Kidney Transplant Recipients. Transplantation Proceedings, 55, (7), 1543-1550. doi:10.1016/j.transproceed.2023.03.092.
Benken, Scott, Mucksavage, Jeffrey, Yudkowsky, Rachel, Woo, Dustin, Collins, Madison, Cheung, Jeffrey JH. (2023). A Multimedia Evaluation of Pharmacy Faculty PowerPoint Slides in a Critical Care Course. American Journal of Pharmaceutical Education, 87, (5), 100066. doi:10.1016/j.ajpe.2023.100066.
Thomas, Riya, Benken, Jamie, Belcher, Rachel, Palmer, Mary, Benedetti, Enrico, Benken, Scott. (2023). 185: VASOPRESSOR EXPOSURE IS ASSOCIATED WITH POOR ALLOGRAFT FUNCTION IN LIVING DONOR RENAL TRANSPLANTS. Critical Care Medicine, 51, (1), 76-76. doi:10.1097/01.ccm.0000906476.38212.f1.
Mashhad, Sara, Belcher, Rachel, Palmer, Mary, Dahlquist, Ashley, Wenzler, Eric, Benedetti, Enrico, Benken, Jamie, Benken, Scott. (2023). 816: EXTENDED-USE STABILITY DATA OF ANGIOTENSIN II INFUSIONS. Critical Care Medicine, 51, (1), 399-399. doi:10.1097/01.ccm.0000908992.67209.a7.
Professional Leadership
ACCP Student Chapter Clinical Specialty Workshop, 4/17/2023 - 4/17/2023
Manuscript Reviewer, 4/1/2023 - Present
ACCP Student Chapter MRCaT Faculty Mentor, 3/1/2023 - Present
ACCP Board of Regents Nomination, 2/1/2023 - Present
2023 SCCM Advanced Pharmacotherapy Course Reviewer, 10/31/2022 - 12/31/2022
AACP Technology in Pharmacy Education and Learning Networking Committee, 9/1/2022 - Present
SCCM CPP Section Research and Scholarship Committee, Clinical Pharmacy and Pharmacology Section, 6/1/2022 - Present
AACP Annual Meeting Poster Abstract Reviewer, 5/1/2022 - 5/31/2022
AACP Pass/Fail Working Group, 3/1/2022 - 12/31/2022
Notable Honors
2023, Frederick P Siegel Teaching Innovation Award, UIC College of Pharmacy
2022, Fellow - American College of Clinical Pharmacists (FCCP), American College of Clinical Pharmacists
2021, Student Preceptor of the Year (Class of 2021), University of Illinois College of Pharmacy
2017, Fellowship - American College of Critical Care Medicine (FCCM), American College of Critical Care Medicine
Education
Degrees:
Pharm.D., University of Cincinnati, United States, 2008
Pharmacy Prerequisite Coursework, Wake Forest University, United States, 2004
Postgraduate Training:
ASHP-Accredited PGY2 Residency in Critical Care Pharmacy, University of Illinois Hospital & Health Sciences System, United States, 2010
ASHP-Accredited PGY1 Pharmacy Practice Residency, University of Illinois Hospital & Health Sciences System, United States, 2009
Licensures and Certifications
Added Qualifications (AQ) – Cardiology, American Pharmacists Association, 4/1/2015 - Present
Board-Certified Pharmacotherapy Specialist, American Pharmacists Association, 12/1/2011 - Present
Advanced Cardiac Life Support, American Heart Association, 1/1/2008 - Present
Basic Life Support, American Heart Association, 1/1/2008 - Present